Quantcast
Channel: WN.com - Articles related to Noven Receives FDA Approval for Brisdelle™ (Paroxetine) Capsules, the First Nonhormonal Therapy for Vasomotor Symptoms Associated with Menopause
Browsing all 189 articles
Browse latest View live

Menopause Drugs from Depomed, Hisamitsu Offer Benefits

Drugs developed for menopausal hot flashes by Depomed Inc. (DEPO) and Hisamitsu Pharmaceutical Co. (4530) are effective, according to staff reviewers at the Food and Drug Administration. While...

View Article


Finding a balance: Lasting confusion over the safety of hormone replacement...

After a decade of rancorous debate over the risks and benefits of menopausal hormone therapy, experts from more than a dozen top medical organizations worldwide have finally come to something...

View Article


Finding a balance with hormone replacement therapy

After a decade of rancorous debate over the risks and benefits of menopausal hormone therapy, experts from more than a dozen top medical organizations worldwide have finally come to something...

View Article

Hot Flash News Flash: HysterSisters.com Releases New Survey, says Women's...

A February 2013 survey of women's attitudes toward menopause symptoms asked 4,500 women at HysterSisters.com about their experiences with hot flashes. Estrogen is the most popular therapy for hot...

View Article

Longer-term treatments

After surgeons removed the tumor from her breast last November, Karen Hajiaskari, of Hamburg, N.Y., was deemed cancer-free. But for the next five years she will take a drug called tamoxifen, a...

View Article


FDA says low dose of antidepressant may help women with hot flashes

DENVER — It”s something all women will face at mid-life — menopause. Symptoms can begin as early as the late 40s and last for an entire decade. Many women will experience fatigue and irritability, but...

View Article

Forest Laboratories, Inc. Announces Commercial Availability of VIIBRYD(TM)...

New Treatment for Major Depressive Disorder in Adults Demonstrated Safe and Effective in Clinical Studies NEW YORK - Forest Laboratories, Inc. (NYSE: FRX) announced today that VIIBRYD(TM) (vilazodone...

View Article

Non-hormonal treatment for hot flashes gains FDA approval

“There are a significant number of women who suffer from hot flashes associated with menopause and who cannot or do not want to use hormonal treatments. This new approval provides them with a new...

View Article


New Survey Reveals Causes that May Affect Compliance with Local Estrogen...

Tweet Send to a Friend PRINCETON, N.J., May 8, 2013 /PRNewswire/ -- Novo Nordisk announced that a new survey of women on local estrogen therapy revealing key insights into reasons for treatment...

View Article


Research and Markets: Vasomotor Symptoms of Menopause - Pipeline Review, H2...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8f9vgv/vasomotor) has announced the addition of Global Markets Direct's new report "Vasomotor Symptoms of...

View Article

Noven Announces FDA Advisory Committee Vote on Investigational Low-Dose...

Tweet MIAMI, FL and NEW YORK, NY, March 4, 2013 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) Reproductive Health Drugs Advisory...

View Article

Lilly Obtains Six Months U.S. Pediatric Exclusivity for Cymbalta®...

My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about LLY Download image...

View Article

Menopause Drugs from Depomed, Hisamitsu Offer Benefits

Drugs developed for menopausal hot flashes by Depomed Inc. (DEPO) and Hisamitsu Pharmaceutical Co. (4530) are effective, according to staff reviewers at the Food and Drug Administration. While...

View Article


Lilly Obtains Six Months U.S. Pediatric Exclusivity for Cymbalta®...

My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about LLY Download image...

View Article

Menopause Drugs from Depomed, Hisamitsu Offer Benefits

Drugs developed for menopausal hot flashes by Depomed Inc. (DEPO) and Hisamitsu Pharmaceutical Co. (4530) are effective, according to staff reviewers at the Food and Drug Administration. While...

View Article


Finding a balance: Lasting confusion over the safety of hormone replacement...

After a decade of rancorous debate over the risks and benefits of menopausal hormone therapy, experts from more than a dozen top medical organizations worldwide have finally come to something...

View Article

Finding a balance with hormone replacement therapy

After a decade of rancorous debate over the risks and benefits of menopausal hormone therapy, experts from more than a dozen top medical organizations worldwide have finally come to something...

View Article


Hot Flash News Flash: HysterSisters.com Releases New Survey, says Women's...

A February 2013 survey of women's attitudes toward menopause symptoms asked 4,500 women at HysterSisters.com about their experiences with hot flashes. Estrogen is the most popular therapy for hot...

View Article

Longer-term treatments

After surgeons removed the tumor from her breast last November, Karen Hajiaskari, of Hamburg, N.Y., was deemed cancer-free. But for the next five years she will take a drug called tamoxifen, a...

View Article

FDA says low dose of antidepressant may help women with hot flashes

DENVER — It”s something all women will face at mid-life — menopause. Symptoms can begin as early as the late 40s and last for an entire decade. Many women will experience fatigue and irritability, but...

View Article
Browsing all 189 articles
Browse latest View live